The Accessible Technology Program will co-fund innovative projects led by the private sector, not-for-profit organizations and research institutes to develop new assistive and adaptive digital devices and technologies in order to make it easier for Canadians with disabilities to more fully participate in the digital economy.
Azure is a San Francisco-based venture capital firm that invests in early stage technology companies. Azure supports its portfolio companies in key aspects such as team building, strategy, operations and governance.
Biomedical Zone is a newly established joint collaboration between Ryerson University and St Michael’s Hospital. Biomedical Zone is:
An innovative collaboration space for entrepreneurs, clinicians, and scientists,
A domain of clinical immersion for entrepreneurs and biomedical innovators to advance commercial ventures, and
A conduit for clinicians and scientists to leverage entrepreneurial resources of the DMZ.
The Biomedical Zone is [...]
Celtic House Venture Partners is an independent Canadian investment firm. Celtic House has collaborated with management teams and repeat entrepreneurs to develop technology companies from the inception phase through to exit, generating 25 initial public offerings and successful acquisitions.
We pride ourselves on taking the unique needs of our customers seriously – and addressing those needs as quickly, pleasantly and professionally as possible. With a unique application process that’s efficient and offers a quick turnaround time and great service from start to finish.
The DMZ at Ryerson University is one of Canada’s largest business incubators for emerging tech startups. The top-ranked university incubator in North America and third in the world, it helps startups succeed by connecting them with customers, advisors, influencers and other entrepreneurs.
The DMZ is open to all startups that meet its criteria — no Ryerson affiliation is required. Startups [...]
Eventi Capital Partners (ECP) is a Toronto-based growth capital investment group, specializing in software-as-a-service, Internet infrastructure services and more recently medical devices. Eventi identifies technology driven operating companies that are in need of both growth capital and greater senior management capability to accelerate their transition from early stage to scalable ventures.
Harris & Harris Group, Inc., has always been involved with founding, incubating and building transformative companies from disruptive science. The investment focus is that of BIOLOGY%2B as investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics.
As the first JLABS to open outside the United States, JLABS @ Toronto joins a network of life science facilities that are based throughout the United States in San Diego (the flagship JLABS), San Francisco, South San Francisco, Boston and Houston. These facilities are home to over 100 early-stage companies advancing pharmaceutical, medical device, consumer and digital health programs.